source
- Biomarker-Driven Treatment Decisions and Managing Progression After Frontline ImmunotherapyUpfront biomarker testing reshapes endometrial cancer care, guiding targeted and immune therapy—and exposing gaps in second-line options.onclive · 2mo ago↗ source
- Extreme heat is worsening faster for Black AmericansBill Cassidy's can't-win conundrum, what RFK Jr. gets right and wrong about antidepressants, and more health newsSTAT · 2mo ago↗ source
- Merck KGaA's clients are stockpiling due to Iran war, supporting guidance boostMerck KGaA appears to have a big-picture view of how the Iran war is affecting the pharma industry so far. The German company is seeing an uptick in demand for its lab equipment products as ...Endpoints